BioSpace News Archive

Larimar Therapeutics, Inc. (Nasdaq:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that patients have been dosed in the third cohort of a Phase 1 clinical trial to evaluate the safety and tolerability of single ascending doses (SAD) of CTI-1601 for the treatment of Friedreich’s ataxia (FA). The trial was previously delayed due to the impact of the COVID-19 pandemic. CTI

Histogen Inc. (“Histogen” or the “Company”) (NASDAQ: HSTO), a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, today announced that it has that it has entered into a common stock purchase agreement for up to $10 million with Lincoln Park Capital Fund, LLC (“Lincoln Park”), a Chicago-based institutional investor. Upon execution of the purchase agreement, Lincoln Park made an initial pur

Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2020 financial results on Monday, August 3, 2020, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q2 2020 Earnings Webcast” hyperlink in the

ELITechGroup will be exhibiting and presenting to a global online audience at the SelectScience® Virtual Clinical Chemistry Summit 2020, taking place July 20-22, 2020.

The Kaiser Permanente Bernard J. Tyson School of Medicine announced today the permanent installation of Bridge (Science of Speed), a major artwork by Los Angeles conceptual artist Glenn Kaino.

In a release issued under the same headline on Monday, July 20th by INmune Bio, Inc. (NASDAQ: INMB) was incorrectly reported with below sentence: The gross proceeds to INmune from this offering are approximately $23.1 million, before deducting underwriting discounts and commissions and other offering expenses payable by INmune. This has been corrected with below: The net proceeds to INmune from this offering are approximately $23.1 millio

AIDS Healthcare Foundation (AHF) today called on the members of the U.S. House of Representatives Subcommittee on Oversight and Investigations to ask tough questions of drug companies testifying on coronavirus vaccines tomorrow.

Burning Rock Biotech Limited (NASDAQ: BNR) today announced that it plans to release its unaudited financial results for the second quarter of 2020 before the U.S. market opens on August 11, 2020.

Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, today announces that Oxford University’s Jenner Institute and Oxford Vaccine Group have taken the next step towards the discovery of a safe, effective and accessible vaccine against coronavirus.

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, continues to expand global capacity and capabilities across its leading pharma services network to support cu